English Overview
Breast cancer management continues to evolve rapidly, particularly in patients with HR+/HER2− disease across early and metastatic settings. This scientific broadcast aims to highlight recent advances in the treatment continuum, with a specific focus on node-positive high-risk early breast cancer (EBC) and the transition to metastatic breast cancer (MBC).
This Activity for
- Resident / Fellow
- Physician
- Clinical Pharmacy
What I will learn?
To enhance healthcare professionals’ understanding and practical application of current evidence in the management of HR+/HER2− breast cancer across early and metastatic settings, with a focus on optimizing treatment decisions for node positive high risk early breast cancer and disease progression to metastatic breast cancer.
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
|
Advancing Care in HR+/HER2- BC: From Node-Positive High-Rish EBC to MBC Certificate
Certificate |
Certificate | Free |
VAT 15% Included
